From: Older patients affected by COVID-19: investigating the existence of biological phenotypes
Biomarker patterns | |||||
---|---|---|---|---|---|
Mean (SD) or N (%) | Overall | Inflammatory N = 33 (40.7) | Organ dysfunction N = 30 (37.1) | Unspecific N = 18 (22.0) | p |
Age (years), mean (SD) | 75.3 (10.9) | 75.7 (8.3) | 79.8 (12.0)b | 66.9 (8.5) | < 0.001 |
Male sex, n (%) | 49 (60.5) | 17 (51.5) | 19 (63.3) | 13 (72.2) | 0.325 |
Living alone, n (%) | 35 (50.0) | 14 (50.0) | 15 (51.7) | 6 (46.2) | 0.946 |
Disability (any ADL or IADL lost), n (%) | 36 (44.0) | 13 (39.4) | 19 (63.3)b | 4 (22.2) | 0.016 |
Clinical Frailty Scale | 4.2 (2.0) | 3.7 (1.8) | 5.3 (1.7)a, b | 3.2 (1.9) | < 0.001 |
Clinical Frailty Scale ≥ 5 | 34 (42.0) | 11 (33.3) | 19 (63.3)a, b | 4 (22.2) | 0.010 |
Prescription drugs, n (%) | 5.1 (3.6) | 5.0 (4.0) | 6.4 (3.3)b | 3.4 (2.6) | 0.018 |
Time from symptoms onset and hospital admittance (days), mean (SD) | 9.5 (8.2) | 10.2 (9.8) | 8.5 (7.4) | 9.9 (6.4) | 0.711 |
Hospital LOS (days), mean (SD) | 24.7 (12.7) | 24.4 (11.0) | 28.3 (16.2) | 20 (8.0) | 0.450 |
In-hospital mortality, n (%) | 15 (18.5) | 6 (18.2) | 7 (23.3) | 2 (11.1) | 0.621 |
Chronic conditions | |||||
Malnutrition, n (%) | 21 (25.9) | 5 (15.2) | 13 (43.3)a | 3 (16.7) | 0.029 |
Heart disease, n (%) | 27 (33.3) | 11 (33.3) | 13 (43.3) | 3 (16.7) | 0.165 |
Stroke, n (%) | 7 (8.6) | 2 (6.1) | 4 (13.3) | 1 (5.6) | 0.594 |
Dementia, n (%) | 16 (19.8) | 5 (15.2) | 9 (30.0) | 2 (11.1) | 0.267 |
Chronic kidney disease, n (%) | 9 (11.1) | 0 (0.0) | 9 (30.0)a, b | 0 (0.0) | < 0.001 |
Solid tumor, n (%) | 9 (11.1) | 6 (18.2) | 1 (3.3) | 2 (11.1) | 0.165 |
COPD, n (%) | 6 (7.4) | 4 (12.1) | 2 (6.7) | 0 (0.0) | 0.364 |
Characteristics at hospital admission | |||||
Respiratory rate ≥ 20/min, n (%) | 32 (39.5) | 18 (54.5) | 11 (36.7) | 3 (16.7) | 0.028 |
Heart rate ≥ 100/min, n (%) | 18 (22.2) | 9 (27.3) | 4 (13.3) | 5 (27.8) | 0.336 |
Fever, n (%) | 25 (30.9) | 12 (36.4) | 7 (23.3) | 6 (33.3) | 0.518 |
Positive chest x-ray, n (%) | 69 (85.2) | 31 (93.9) | 23 (76.7) | 15 (83.3) | 0.151 |
Brescia COVID scale | 0.022 | ||||
Ambient air, n (%) | 14 (17.3) | 6 (18.2) | 7 (23.3)a, b | 1 (5.6) | |
Oxygen support, n (%) | 31 (38.3) | 9 (27.3) | 13 (43.3)a | 9 (50.0) | |
Oxygen support, distressed patient, n (%) | 24 (29.6) | 11 (33.3) | 10 (33.3) | 3 (16.7) | |
Continuous Positive Air Pressure ventilation, n (%) | 12 (14.8) | 7 (21.2) | 0 (0.0)a, b | 5 (27.8) | |
White blood cells (103/mL), mean (SD) | 7.3 (3.2) | 7.3 (3.0) | 7.4 (3.3) | 7.0 (3.3) | 0.918 |
C-reactive protein (mg/mL), mean (SD) | 8.3 (6.8) | 8.2 (5.7) | 7.5 (7.9) | 9.7 (6.9) | 0.595 |
Lymphocytes (103/mL, mean (SD) | 1.2 (0.5) | 1.1 (0.5) | 1.3 (0.6) | 1.2 (0.6) | 0.625 |
Creatinine (mg/mL), mean (SD) | 1.4 (1.5) | 1.0 (0.3) | 2.1 (2.3)a, b | 0.9 (0.2) | 0.004 |